Eltrombopag in chronic myelomonocytic leukemia with severe thrombocytopenia. A Groupe Francophone des Myélodysplasies (GFM) study-Reference-Cited by-同舟云学术

Eltrombopag in chronic myelomonocytic leukemia with severe thrombocytopenia. A Groupe Francophone des Myélodysplasies (GFM) study

Published:2024-09-12 Issue: Volume: Page:
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Rabian Florence,Chevret Sylvie,Gruson Bérengère,Thépot Sylvain,Walter-Petrich Anouk,Braun Thorsten,Vey Norbert^ORCID,Torregrosa-Diaz José Miguel,Peterlin Pierre,Toma Andrea,D’Aveni Maud^ORCID,Delaunay Jacques,Legros Laurence,Droin Nathalie,Chermat Fatiha,Lusina Daniel,Adès Lionel^ORCID,Sapena Rosa,Solary Eric^ORCID,Fenaux Pierre,Itzykson Raphael^ORCID

Funder

Institut National Du Cancer

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41375-024-02402-8.pdf

Reference11 articles.

1. Solary E, Itzykson R. How I treat chronic myelomonocytic leukemia. Blood. 2017;130:126–36.

2. Itzykson R, Fenaux P, Bowen D, Cross NCP, Cortes J, De Witte T, et al. Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet. Hemasphere. 2018;2:e150.

3. Oliva EN, Riva M, Niscola P, Santini V, Breccia M, Giai V, et al. Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS). J Clin Oncol. 2023;41:4486–96.

4. Modi Y, Shaaban H, Gauchan D, Maroules M. Successful treatment of severe thrombocytopenia with the use of thrombopoeitin receptor agonist eltrombopag in a patient with chronic myelomonocytic leukemia. J Oncol Pharm Pr. 2015;21:74–75.

5. Gao Y, Gong M, Zhang C, Kong X, Ma Y. Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article. Medicine. 2017;96:e8337.